Bevacizumab/Erlotinib Combinations in the Treatment of Metastatic Renal Cell Carcinoma (RCC)

Reviewer: Neha Vapiwala, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 7 de noviembre del 2005

Translation for this article does not exist